Literature DB >> 19555687

Identification of transplantable dopamine neuron precursors at different stages of midbrain neurogenesis.

Marie E Jönsson1, Yuichi Ono, Anders Björklund, Lachlan H Thompson.   

Abstract

Protocols used for generation of mesencephalic dopamine (mesDA) neurons from stem cells, or fetal brain tissue, invariably result in cell preparations that are highly mixed in composition, containing mesDA neuron precursors in various states of fate commitment and differentiation. For further optimisation and refinement of these procedures it is essential to determine the optimal stage of development and phenotypic characteristics of cells used for grafting. We have used fluorescence-activated cell sorting procedures to isolate mesDA precursors in defined stages of differentiation from mouse ventral mesencephalon (VM), at embryonic day 10.5 (E10.5), when the mesDA neuron domain consists of proliferative radial glia-like cells expressing the mesDA neuron determinant Lmx1a and the floorplate marker Corin, and at E12.5, when the VM has expanded to comprise a mixture of proliferative progenitors, neuroblasts and young neurons. The sorted cells were transplanted to the striatum of 6-hydroxydopamine-lesioned rats. Results show that the Lmx1a/Corin-expressing ventricular zone progenitors, which are the source of mesDA neurons in grafts from E10.5 VM, had lost this capacity at E12.5. At this later stage all transplantable mesDA precursors resided in the intermediate zone as postmitotic Nurr1-expressing neuroblasts. The more differentiated, TH-expressing cells survived sorting and transplantation poorly. We also provide evidence that, during early mesDA neurogenesis, the progenitors for nigral mesDA neurons segregate to lateral parts of the Lmx1a-expressing domain and can be selectively isolated based on their level of Corin expression. These results have implications for current efforts to develop well-characterized stem cell-derived mesDA progenitor cell preparations for cell therapy.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19555687     DOI: 10.1016/j.expneurol.2009.06.006

Source DB:  PubMed          Journal:  Exp Neurol        ISSN: 0014-4886            Impact factor:   5.330


  25 in total

1.  Tracking differentiating neural progenitors in pluripotent cultures using microRNA-regulated lentiviral vectors.

Authors:  Rohit Sachdeva; Marie E Jönsson; Jenny Nelander; Agnete Kirkeby; Carolina Guibentif; Bernhard Gentner; Luigi Naldini; Anders Björklund; Malin Parmar; Johan Jakobsson
Journal:  Proc Natl Acad Sci U S A       Date:  2010-06-07       Impact factor: 11.205

Review 2.  Pluripotent stem cell-based therapy for Parkinson's disease: Current status and future prospects.

Authors:  Kai-C Sonntag; Bin Song; Nayeon Lee; Jin Hyuk Jung; Young Cha; Pierre Leblanc; Carolyn Neff; Sek Won Kong; Bob S Carter; Jeffrey Schweitzer; Kwang-Soo Kim
Journal:  Prog Neurobiol       Date:  2018-04-11       Impact factor: 11.685

3.  Nucleotides affect neurogenesis and dopaminergic differentiation of mouse fetal midbrain-derived neural precursor cells.

Authors:  Jasmin Delic; Herbert Zimmermann
Journal:  Purinergic Signal       Date:  2011-01-06       Impact factor: 3.765

4.  Peptide-Based Scaffolds for the Culture and Transplantation of Human Dopaminergic Neurons.

Authors:  Nicola L Francis; Nanxia Zhao; Hannah R Calvelli; Astha Saini; Janace J Gifford; George C Wagner; Rick I Cohen; Zhiping P Pang; Prabhas V Moghe
Journal:  Tissue Eng Part A       Date:  2019-10-17       Impact factor: 3.845

5.  Isolation of LMX1a Ventral Midbrain Progenitors Improves the Safety and Predictability of Human Pluripotent Stem Cell-Derived Neural Transplants in Parkinsonian Disease.

Authors:  Isabelle R de Luzy; Jonathan C Niclis; Carlos W Gantner; Jessica A Kauhausen; Cameron P J Hunt; Charlotte Ermine; Colin W Pouton; Lachlan H Thompson; Clare L Parish
Journal:  J Neurosci       Date:  2019-10-22       Impact factor: 6.167

6.  Genome wide profiling of dopaminergic neurons derived from human embryonic and induced pluripotent stem cells.

Authors:  Olga Momčilović; Qiuyue Liu; Andrzej Swistowski; Tatiane Russo-Tait; Yiqiang Zhao; Mahendra S Rao; Xianmin Zeng
Journal:  Stem Cells Dev       Date:  2013-11-07       Impact factor: 3.272

Review 7.  Cell Therapy for Parkinson's Disease: New Hope from Reprogramming Technologies.

Authors:  Zhiguo Chen
Journal:  Aging Dis       Date:  2015-11-17       Impact factor: 6.745

8.  Gli1 is an inducing factor in generating floor plate progenitor cells from human embryonic stem cells.

Authors:  Mark Denham; Lachlan H Thompson; Jessie Leung; Alice Pébay; Anders Björklund; Mirella Dottori
Journal:  Stem Cells       Date:  2010-10       Impact factor: 6.277

9.  MicroRNA-124 is a subventricular zone neuronal fate determinant.

Authors:  Malin Åkerblom; Rohit Sachdeva; Isabelle Barde; Sonia Verp; Bernhard Gentner; Didier Trono; Johan Jakobsson
Journal:  J Neurosci       Date:  2012-06-27       Impact factor: 6.167

10.  Spatiotemporally separable Shh domains in the midbrain define distinct dopaminergic progenitor pools.

Authors:  Milan Joksimovic; Angela Anderegg; Anil Roy; Laura Campochiaro; Beth Yun; Raja Kittappa; Ronald McKay; Rajeshwar Awatramani
Journal:  Proc Natl Acad Sci U S A       Date:  2009-10-22       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.